{"id":"epinastine-nasal-spray","safety":{"commonSideEffects":[{"rate":"5%","effect":"Nasal discomfort"},{"rate":"3%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1200491","moleculeType":"Small molecule","molecularWeight":"285.78"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"By antagonizing the H1-receptors, epinastine prevents the vasodilation and increased vascular permeability caused by histamine, which are key contributors to nasal congestion and other symptoms of allergic rhinitis.","oneSentence":"Epinastine is a selective histamine H1-receptor antagonist that blocks the action of histamine on nasal mucosa, reducing symptoms of allergic rhinitis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:51:21.359Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"}]},"trialDetails":[{"nctId":"NCT00564421","phase":"PHASE3","title":"Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-12-18","conditions":"Seasonal Allergic Rhinitis","enrollment":798},{"nctId":"NCT01382654","phase":"PHASE2","title":"Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-09","conditions":"Allergic Rhinitis","enrollment":131},{"nctId":"NCT00407927","phase":"PHASE2","title":"A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-12","conditions":"Seasonal Allergic Rhinitis","enrollment":571}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Epinastine Nasal Spray","genericName":"Epinastine Nasal Spray","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Epinastine is a selective histamine H1-receptor antagonist that blocks the action of histamine on nasal mucosa, reducing symptoms of allergic rhinitis. Used for Allergic rhinitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}